Among all genetic factors linked to Alzheimer's disease, the APOE gene is one of the most extensively studied.
The APOE gene helps regulate how the body processes and transports cholesterol and other fats. Scientists have identified several variants of this gene, including APOE2, APOE3, and APOE4.
Individuals carrying the APOE4 variant may have a higher lifetime risk of developing Alzheimer's disease compared with those who do not carry this variant.
However, carrying APOE4 does not mean that a person will inevitably develop dementia.
This distinction is important.
Genetics influences risk, but it does not guarantee outcomes.
Research increasingly suggests that cardiovascular health, physical activity, sleep quality, nutrition, metabolic health, and social engagement may all influence long-term brain health.
For this reason, genetic information should be viewed as one piece of a larger health picture.
Understanding genetic risk may help individuals make more informed decisions about prevention, monitoring, and lifestyle choices throughout life.
The goal of genetic testing is not to predict the future with certainty.
The goal is to better understand risk and support personalized prevention strategies.
